Archive for February, 2008



Thalidomide shows promise for treatment of recurrent ovarian cancer

Friday 29 February 2008 @ 11:02 pm

Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a Unive

More: continued here




Anaemia drug linked to blood clots, death in cancer patients

Friday 29 February 2008 @ 8:02 pm

Treating anaemia with a class of drugs known as erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in

More: continued here




Positive CHMP Opinion For Histologically-Based Use Of ALIMTA(R

Thursday 28 February 2008 @ 4:02 am

Positive CHMP Opinion For Histologically-Based Use Of ALIMTA(R Medical News Today - Pemetrexed is also indicated, in combination with cisplatin, for the treatment of patients with malignant pleural mesothelioma These histologies are

More: continued here




Bowel cancer increasing in Australia

Wednesday 27 February 2008 @ 10:02 pm

A national report released on 27 February 2008 by the Australian Institute of Health and Welfare (AIHW) presents a mixed bag on favourable and unfavourable trends in chronic diseases over time.

More: continued here




Asbestos - Confronting a Health Risk in your House

Wednesday 27 February 2008 @ 11:02 am

Asbestos is a flame retardant insulation that has been used in a variety of materials from construction products to textiles. It was an extremely popular material in a variety of industries until it was determined that the fiber caused a deadly form of cancer. Now, many people may have asbestos products in their house and not even know it. It is important to identify these products and avoid them if they cannot be removed immediately.

More: continued here




Positive CHMP Opinion For Histologically-Based Use Of ALIMTA(R) (Pemetrexed For Injection) For Most Common Lung Cancer (Medical News Today)

Tuesday 26 February 2008 @ 8:02 pm

Eli Lilly and Company (NYSE: LLY)announced that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the centralized use of ALIMTA® (pemetrexed for injection), in the first-line treatment of advanced non-small cell lung cancer (NSCLC), the most common form of lung cancer.

More: continued here




Fourfold increase in remission rates for multiple myeloma patients

Tuesday 26 February 2008 @ 8:02 pm

Researchers have found that multiple myeloma patients given the anti-cancer drug Velcade (bortezomib) in combination with a more commonly used drug showed a fourfold increase in complete remission rat

More: continued here




Positive CHMP Opinion For Histologically-Based Use Of ALIMTA(R

Tuesday 26 February 2008 @ 3:02 pm

Pemetrexed is also indicated, in combination with cisplatin, for the treatment of patients with malignant pleural mesothelioma (MPM) whose disease is unresectable or who are otherwise not candidates for curative surgery.

More: continued here




Mesothelioma Diagnosis - What You Need To Know

Tuesday 26 February 2008 @ 11:02 am

Mesothelioma diagnosis can be done through chest x-ray. The typical abnormalities seen on chest x-ray in patients with malignant mesohtelioma are pleural effusion (a collection of fluid in the space between the 2 layers of the pleura), or it is called pleural thickening.

More: continued here




26 February 2008 (PharmiWeb)

Tuesday 26 February 2008 @ 11:02 am

INDIANAPOLIS, IND., USA, 22 February 2008 – Eli Lilly and Company (NYSE: LLY) today announced that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the centralized use of ALIMTA® (pemetrexed for injection), in the first-line treatment of advanced non-small cell lung cancer (NSCLC), the most common form of lung cancer.

More: continued here




«« Previous Posts